Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States

References

• Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015 Jul;2(1):15016. doi: 10.1038/nrdp.2015.16
   Google Scholar
• Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013 Jul 18;369(3):255–263.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR–5):1–30.
   PubMedGoogle Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
   PubMedGoogle Scholar
• Gordon JE. Chickenpox: an epidemiological review. Am J Med Sci. 1962 Sep;244:362–389.
   PubMed Web of Science ®Google Scholar
• Grose C. Pangaea and the Out-of-Africa Model of Varicella-Zoster Virus Evolution and Phylogeography. J Virol. 2012 Sep;86(18):9558–9565.
   PubMed Web of Science ®Google Scholar
• Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes-zoster. Epidemiol Infect. 1992;108:513–528.
   PubMed Web of Science ®Google Scholar
• Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Mathemat Biol. 1999;61:1031–1064.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Gay NJ, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000 Dec;125(3):651–669.
   PubMed Web of Science ®Google Scholar
• Brisson M, Gay NJ, Edmunds WJ, et al. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20:2500–2507.
   PubMed Web of Science ®Google Scholar
• Horn J, Karch A, Damm O, et al. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother. 2016;12:1766–1776.
   PubMed Web of Science ®Google Scholar
• Gidding HF, Brisson M, Macintyre CR, et al. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health. 2005;29:544–551.
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Melegaro A, Zagheni E, et al. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011;29(13):2411–2420.
   PubMed Web of Science ®Google Scholar
• Karhunen M, Leino T, Salo H, et al. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect. 2010;138(4):469–481.
   PubMed Web of Science ®Google Scholar
• Riche B, Bricout H, Kürzinger ML, et al. Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns. Expert Rev Vaccines. 2016;15(7):927–936.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. Plos One. 2013;8:e66485.
   PubMed Web of Science ®Google Scholar
• Talbird SE, La EM, Mauskopf J, et al. Understanding the role of exogenous boosting in modeling varicella vaccination. Expert Rev Vaccines. 2018 Nov;17(11):1021–1035.
   PubMed Web of Science ®Google Scholar
• Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines. 2014 Mar;2(2):39–55.
   PubMedGoogle Scholar
• Wutzler P, Bonanni P, Burgess M, et al. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017 Aug;16(8):833–843.
   PubMed Web of Science ®Google Scholar
• Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265–288.
   PubMedGoogle Scholar
• Backround paper on varicella vaccines- SAGE working group. [cited 2019 Jul 26]. Available from: http://www.who.int/immunization/sage/meetings/2014/april/presentations_background_docs/en/;
   Google Scholar
• Preblud SR. Age-specific risks of varicella complications. Pediatrics. 1981 Jul;68(1):14–17.
   PubMed Web of Science ®Google Scholar
• Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin N Amer. 1996;10:571–581.
   PubMed Web of Science ®Google Scholar
• Zhou F, Harpaz R, Jumaan AO, et al. Impact of varicella vaccination on health care utilization. JAMA. 2005 Aug 17;294(7):797–802.
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Kruszon-Moran D, Seward JF, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol. 2003;70(Suppl 1):S111–8.
   PubMedGoogle Scholar
• CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep. 1996;45(No. RR–11):1–36.
   Google Scholar
• Marin M, Güris D, Chaves SS, et al. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR–4):1–40.
   PubMedGoogle Scholar
• Seward J, Galil K, Wharton M. Epidemiology of Varicella. In: Arvin A, Gershon A, editors. Varicella-Zoster Virus. Cambridge: Cambridge University Press; 2000. p. 187–205.
   Google Scholar
• Takahashi M, Otsuka T, Okuno Y, et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2:1288–1290.
   PubMed Web of Science ®Google Scholar
• Merck & Co., Inc. VARIVAX [Package insert]. Whitehouse Station, NJ: Merck & Co., Inc. 1995. [cited 2019 Jul 26]. Available from: https://www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdf
   Google Scholar
• Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016 Mar;137(3):e20153741.
   PubMed Web of Science ®Google Scholar
• Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the U.S. after implementation of the vaccination program. Pediatrics. 2011;128(2):214–220.
   PubMed Web of Science ®Google Scholar
• Varicella vaccination coverage among children 19–35 months by State, HHS Region, and the United States, National Immunization Survey-Child (NIS-Child), 1996 through 2017. [cited 2019 Jul 26]. Available from: https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/data-reports/varicella/trend/index.html
   Google Scholar
• CDC. Decline in annual incidence of varicella—selected states, 1990–2001. MMWR Morb Mortal Wkly Rep. 2003;52(37):884–885.
   Google Scholar
• Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. JAMA. 2002;287(5):606–611.
   PubMed Web of Science ®Google Scholar
• Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites—united States, 1995–2005. J Infect Dis. 2008;197(suppl 2):S71–S75.
   PubMed Web of Science ®Google Scholar
• Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003. BMC Public Health. 2005 Jun 16;5:68.
   PubMed Web of Science ®Google Scholar
• Bialek SR, Perella D, Zhang J, et al. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics. 2013;132(5):e1134–40.
   PubMed Web of Science ®Google Scholar
• Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008 Sep;122(3):e744–51.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics. 2006 Jun;117(6):e1070–7.
   PubMed Web of Science ®Google Scholar
• Parker AA, Reynolds MA, Leung J, et al. Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement–Maine, 2006. J Infect Dis. 2008 Mar 1;197(Suppl 2):S101–7.
   PubMedGoogle Scholar
• Advisory Committee on Immunization Practices (ACIP) Summary Report: June 22-23. 2011(Meeting minutes) Washington, DC: US Department of Health and Human Services, CDC. 2014. [cited 2019 Jul 26]. Available from: http://www.cdc.gov/vaccines/acip/meetings/downloads/minarchive/min-2014-10.pdf
   Google Scholar
• Lopez AS, Cardemil C, Pabst LJ, et al. Two-dose varicella vaccination coverage among children aged 7 years–six sentinel sites, United States, 2006–2012. MMWR Morb Mortal Wkly Rep. 2014;63:174–177.
   PubMed Web of Science ®Google Scholar
• Seither R, Calhoun K, Knighton CL, et al. Vaccination coverage among children in kindergarten - United States, 2014-15 school year. MMWR Morb Mortal Wkly Rep. 2015 Aug 28;64(33):897–904.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016. MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874–882.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R. Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994–2012. J Ped Infect Dis. 2016;5(4):395–402.
   Web of Science ®Google Scholar
• Baxter R, Tran TN, Ray P, et al. Impact of vaccination on the epidemiology of varicella: 1995–2009. Pediatrics. 2014 Jul;134(1):24–30.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Marin M. Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program - United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2016;65(34):902–905.
   PubMed Web of Science ®Google Scholar
• Hales CM, Harpaz R, Bialek SR. Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: implications for interpretation of health care-based studies. Ann Epidemiol. 2016 Jun;26(6):441–446.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R. Interpretation of data derived from healthcare settings: cautionary findings related to parenthood status. American Public Health Association 2018 Annual Meeting & Expo; 2018 Nov 10–14; San Diego, CA, Abstract, 416612. [cited 2019 Jul 26]. Available from: https://apha.confex.com/apha/2018/meetingapp.cgi/Paper/416612
   Google Scholar
• Lu PJ, Euler GL, Jumaan AO, et al. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009 Feb 5;27(6):882–887.
   PubMed Web of Science ®Google Scholar
• Bowsher D. The lifetime occurrence of Herpes zoster and prevalence of postherpetic neuralgia: A retrospective survey in an elderly population. Eur J pain. 1999;3(4):335e42.
   Web of Science ®Google Scholar
• Schmader K, George LK, Newton R, et al. The accuracy of self-report of herpes zoster. J Clin Epidemiol. 1994 Nov;47(11):1271–1276.
   PubMed Web of Science ®Google Scholar
• Soni A, Hill SC. Average Annual Health Care Use and Expenses for Shingles among the U.S. Civilian Noninstitutionalized Population, 2003e2005. Statistical Brief #194 Rockville, MD. 2007. [cited 2019 Jul 26]. Available from: http://www.meps.ahrq.gov/data_files/publications/st194/stat194.pdf
   Google Scholar
• Tseng HF, Smith N, Harpaz R, et al. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305:160–166.
   PubMed Web of Science ®Google Scholar
• Baxter R, Bartlett J, Fireman B, et al. Long-term effectiveness of the live zoster vaccine in preventing shingles: a cohort study. Am J Epidemiol. 2018 Jan 1;187(1):161–169.
   PubMed Web of Science ®Google Scholar
• Tartof S, Slezak J, Hechter R, et al. A Cohort Study of Risk Factors for Herpes Zoster in Men in Southern California; 2013 Oct 2–6; San Francisco, CA: IDWEEK, Abstract 1747. [cited 2019 Jul 26]. Available from: https://idsa.confex.com/idsa/2013/webprogram/Paper40461.html
   Google Scholar
• Harpaz R, Dahl RM. Administrative data to explore the role of family history as a risk factor for herpes zoster. Mayo Clin Proc. 2018 Jun;93(6):747–751.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP, Wollan P, et al. Increasing incidence of herpes zoster over 60-year period from a population-based study. Clin Infect Dis. 2016 Jul 15;63(2):221–226.
   PubMed Web of Science ®Google Scholar
• Guess HA, Broughton DD, Melton LJ 3rd, et al. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics. 1985;76(4):512–517.
   PubMed Web of Science ®Google Scholar
• Petursson G, Helgason S, Gudmundsson S, et al. Herpes zoster in children and adolescents. Pediatr Infect Dis J. 1998;17:905–908.
   PubMed Web of Science ®Google Scholar
• Stein M, Cohen R, Bromberg M, et al. Herpes zoster in a partially vaccinated pediatric population in central Israel. Pediatr Infect Dis J. 2012 Sep;31(9):906–909.
   PubMed Web of Science ®Google Scholar
• Winkelmann RK, Perry HO. Herpes zoster in children. JAMA. 1959;171:876–880.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Smith N, Marcy SM, et al. Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002–2008. Pediatr Infect Dis J. 2009 Dec;28(12):1069–1072.
   PubMed Web of Science ®Google Scholar
• Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009 Nov;28(11):954–959.
   PubMed Web of Science ®Google Scholar
• Weinmann S, Chun C, Schmid DS, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis. 2013 Dec 1;208(11):1859–1868.
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Riedlinger K, Chun C, et al. Incidence of herpes zoster, 1997–2002. Epidemiol Infect. 2005;133(2):245–253.
   PubMed Web of Science ®Google Scholar
• Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med. 1995;155(15):1605–1609.
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Ray P, et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr Infect Dis J. 1999;18(12):1041–1046.
   PubMed Web of Science ®Google Scholar
• Weinmann S, Vandermeer M, Roberts M, et al. Positive predictive value of ICD-9 code for herpes zoster among children during the varicella vaccine era. Pediatr Infect Dis J. 2016 Apr;35(4):459–460.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Reynolds MA, Harpaz R. Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clin Infect Dis. 2008 Sep 15;47(6):754–759.
   PubMed Web of Science ®Google Scholar
• Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the prevaricella vaccine era. J Infect Dis. 2000;181(6):1897–1905.
   PubMed Web of Science ®Google Scholar
• Valente N, Cocchio S, Stefanati A, et al. Temporal trends in herpes zoster-related hospitalizations in Italy, 2001–2013: differences between regions that have or have not implemented varicella vaccination. Aging Clin Exp Res. 2017 Aug;29(4):771–779.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007 Nov;82(11):1341–1349.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Wernecke M, Kelman J, et al. Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccine in the medicare population ages 65 years and older. Clin Infect Dis. 2017 Feb 27;64(6):785–793.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001 Oct;127(2): 305–4.
   PubMed Web of Science ®Google Scholar
• Russell ML, Dover DC, Simmonds KA, et al. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine. 2014 Oct 29;32(47):6319–6324.
   PubMed Web of Science ®Google Scholar
• Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol. 2008 Dec;29(12):1157–1163.
   PubMed Web of Science ®Google Scholar
• Schröder C, Enders D, Schink T, et al. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J Infect. 2017 Sep;75(3):207–215.
   PubMed Web of Science ®Google Scholar
• Matthews I, Lu X, Dawson H, et al. Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom. Vaccine. 2018 Nov 12;36(46):7105–7111.
   PubMed Web of Science ®Google Scholar
• Marra F, Chong M, Najafzadeh M. Increasing incidence associated with herpes zoster infection in British Columbia, Canada. BMC Infect Dis. 2016 Oct 20;16(1):589.
   PubMedGoogle Scholar
• Cocchio S, Baldovin T, Furlan P, et al. Cross-sectional study on hospitalizations related to herpes zoster in an Italian region, 2008–2016. Aging Clin Exp Res. 2019;31(1):145-150.
   Web of Science ®Google Scholar
• Humes EA, Weinberger DM, Kudish KS, et al. Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, Connecticut, 1994–2012. Open Forum Infect Dis. 2015 Jan 28;2(1):ofv001.
   PubMed Web of Science ®Google Scholar
• Esteban-Vasallo MD, Domínguez-Berjón MF, Gil-Prieto R. Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003–2013. J Infect. 2015 Jul;71(1):85–92.
   PubMed Web of Science ®Google Scholar
• Coplan P, Black S, Rojas C, et al. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatric Infect Dis J. 2001;20:641–645.
   PubMed Web of Science ®Google Scholar
• Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10(12):3594–3600.
   PubMed Web of Science ®Google Scholar
• García-Doval I, Pérez-Zafrilla B, Descalzo MA, et al. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis. 2010 Oct;69(10):1751–1755.
   PubMed Web of Science ®Google Scholar
• Murray SG, Schmajuk G, Trupin L, et al. National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia. PLoS One. 2016 Jan 5;11(1):e0144918.
   PubMed Web of Science ®Google Scholar
• Gil A, Gil R, Alvaro A, et al. Burden of herpes zoster requiring hospitalization in Spain during a seven year period (1998e2004). BMC Infect Dis. 2009;9:55.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Wollan P, St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol. 2011 Nov 1;174(9):1054–1061.
   PubMed Web of Science ®Google Scholar
• Klompas M, Kulldorff M, Vilk Y, et al. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc. 2011 Dec;86(12):1146–1153.
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–2284.
   PubMed Web of Science ®Google Scholar
• Zostavax (zoster vaccine, live) [package insert]. Whitehouse Station, NJ: Merck & Co., Inc.; 2009 [cited 2019 Jul 26]. Available from: http://www.merck.com/product/usa/pi_circulars/z/zostavax/zostavax_pi2.pdf
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years. MMWR. 2011;60:1528.
   PubMedGoogle Scholar
• Tseng HF, Harpaz R, Luo Y, et al. Declining effectiveness of herpes zoster vaccine in adults aged ≥60 years. J Infect Dis. 2016;213(12):1872–1875.
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Andrews N, Keel P, et al. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health. 2018 Feb;3(2):e82–e90.
   PubMed Web of Science ®Google Scholar
• Walker JL, Andrews NJ, Amirthalingam G, et al. Effectiveness of herpes zoster vaccination in an older United Kingdom population. Vaccine. 2018 Apr 19;36(17):2371–2377.
   PubMed Web of Science ®Google Scholar
• Morrison VA, Johnson GR, Schmader KE, et al. Shingles prevention study group. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis. 2015;60(6):900–909.
   PubMed Web of Science ®Google Scholar
• McDonald BM, Dover DC, Simmonds KA, et al. The effectiveness of shingles vaccine among Albertans aged 50 years or older: A retrospective cohort study. Vaccine. 2017 Dec 15;35(50):6984–6989.
   PubMed Web of Science ®Google Scholar
• Lu PJ, Euler GL, Harpaz R. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med. 2011 Feb;40(2):e1–6.
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O’Halloran A, et al. Centers for Disease Control and Prevention (CDC). noninfluenza vaccination coverage among adults - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):95–102.
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O’Halloran A, et al. Centers for Disease Control and Prevention (CDC). vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):95–102.
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O’Halloran A, et al. Centers for Disease Control and Prevention (CDC). Surveillance of vaccination coverage among adult populations - United States, 2014. MMWR Surveill Summ. 2016 Feb 5;65(1):1–36.
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O’Halloran A, et al. Surveillance of vaccination coverage among adult populations - United States, 2015. MMWR Surveill Summ. 2017 May 5;66(11):1–28.
   PubMed Web of Science ®Google Scholar
• SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) [package insert]. Research Triangle Park, NC: GlaxoSmithKline. [cited 2019 Jul 26]. Available from: https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF
   Google Scholar
• Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):103–108.
   PubMed Web of Science ®Google Scholar
• CDC. Current vaccine shortages & delays. healthcare Professionals/Providers Home. https://www.cdc.gov/vaccines/hcp/clinical-resources/shortages.html#note4. Published 2018. Last accessed 2019 Jul 26.
   Google Scholar
• Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004 Jan;4(1):26–33.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP. Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2017 Dec;92(12):1806–1821.
   PubMed Web of Science ®Google Scholar
• Nagel MA, Rempel A, Huntington J, et al. Frequency and abundance of alphaherpesvirus DNA in human thoracic sympathetic ganglia. J Virol. 2014 Jul;88(14):8189–8192.
   PubMed Web of Science ®Google Scholar
• Gillard P, Povey M, Carryn S. Clinically vs. serologically identified varicella: A hidden Infection burden. Lessons of 10-year follow-up in varicella endemic countries. Open Forum Infect Dis. 2018 Nov;5(Suppl 1):S701.
   Google Scholar
• Gershon AA, Chen J, Davis L, et al. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc. 2012;123:17–35.
   PubMedGoogle Scholar
• David TJ, Williams ML. Herpes zoster in infancy. Scand J Infect Dis. 1979;11(3):185–186.
   PubMed Web of Science ®Google Scholar
• Baba K, Yabuuchi H, Takahashi M, et al. Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood. J Pediatr. 1982 Jun;100(6):881–885.
   PubMed Web of Science ®Google Scholar
• Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med. 1986 Jun 12;314(24):1542–1546.
   PubMed Web of Science ®Google Scholar
• Brunell PA, Kotchmar GS. Zoster in infancy: failure to maintain virus latency following intrauterine infection. J Pediatr. 1981;98:71–73.
   PubMed Web of Science ®Google Scholar
• Baba K, Yabuuchi H, Takahashi M, et al. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. J Pediatr. 1986;108:372–377.
   PubMed Web of Science ®Google Scholar
• Singleton JA, Jumaan AO, Seward JF, et al. Varicella and herpes zoster surveillance in the U.S., 1970–1994. 41st Annual Meeting of the Infectious Diseases Society of America, 2003 Oct 9–12,. San Diego, CA, Abstract # 899. [cited 2019 Jul 26]. Available from: https://idsa.confex.com/idsa/2003/webprogram/Paper18592.html
   Google Scholar
• Nardone A, de Ory F, Carton M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007 Nov 7;25(45):7866–7872.
   PubMed Web of Science ®Google Scholar
• Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis. 2008 Mar 1;197(Suppl 2):S165–9.
   PubMed Web of Science ®Google Scholar
• Breuer J. Molecular genetic insights into varicella zoster virus, the vOka vaccine strain, and the pathogenesis of latency and reactivation. J Infect Dis. 2018 Sep 22;218(suppl_2):S75–S80.
   PubMedGoogle Scholar
• Norberg P, Depledge DP, Kundu S, et al. Recombination of Globally Circulating Varicella-Zoster Virus. J Virol. 2015 Jul;89(14):7133–7146.
   PubMed Web of Science ®Google Scholar
• Hambleton S, Steinberg SP, Larussa PS, et al. Risk of herpes zoster in adults immunized with varicella vaccine. J Infect Dis. 2008 Mar 1;197(Suppl 2):S196–9.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Schmid DS, Harpaz R, et al. Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis. 2014 Apr;58(8):1125–1128.
   PubMed Web of Science ®Google Scholar
• Chun C, Weinmann S, Riedlinger K, et al. Laboratory characteristics of suspected herpes zoster in vaccinated children. Pediatr Infect Dis J. 2011;30:719–721.
   PubMed Web of Science ®Google Scholar
• Brunell PA, Taylor-Wiedeman J, Geiser CF, et al. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics. 1986 Jan;77(1):53–56.
   PubMed Web of Science ®Google Scholar
• Hardy I, Gershon AA, Steinberg SP, et al. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. varicella vaccine collaborative study group. N Engl J Med. 1991 Nov 28;325(22):1545–1550.
   PubMed Web of Science ®Google Scholar
• Gershon AA, LaRussa P, Steinberg S, et al. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis. 1996 Feb;173(2):450–453.
   PubMed Web of Science ®Google Scholar
• Weinmann S, Naleway AL, Koppolu P, et al. Incidence of Herpes Zoster Among Children: 2003–2014. Pediatrics. 2019 Jul;144(1):pii: e20182917. Epub 2019 Jun 10.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Leung JW. The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: changing Patterns Among Children. Clin Infect Dis. 2019;69(2):345–347.
   Google Scholar
• Baxter R, Ray P, Tran TN, et al. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study. Pediatrics. 2013 May;131(5):e1389–96.
   PubMed Web of Science ®Google Scholar
• Wolfson LJ, Daniels VJ, Altland A, et al. The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991–2016. Clin Infect Dis. 2019 Apr 24;pii: ciz305. doi:10.1093/cid/ciz305.
   PubMed Web of Science ®Google Scholar
• Chidiac C, Bruxelle J, Daures JP, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis. 2001;33(1):62–69.
   PubMed Web of Science ®Google Scholar
• Pinchinat S, Cebrián-Cuenca AM, Bricout H, et al. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013 Apr;10(13):170.
   Google Scholar
• Kim YJ, Lee CN, Lim CY, et al. Population-based study of the epidemiology of herpes zoster in Korea. J Korean Med Sci. 2014 Dec;29(12):1706–1710.
   PubMedGoogle Scholar
• Dworkin RH, Nagasako EM, Johnson RW, et al. Acute pain in herpes zoster: the famciclovir database project. Pain. 2001 Oct;94(1):113–119.
   PubMed Web of Science ®Google Scholar
• Parruti G, Tontodonati M, Rebuzzi C, et al.; VZV Pain Study Group. Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med. 2010 Oct;11(8):58.
   Google Scholar
• Cockrill JA. Herpes zoster, active component, U.S. Armed Forces, 2000–2010. MSMR. 2011 Jul;18(7):16–18.
   PubMedGoogle Scholar
• Tseng HF, Smith N, Marcy SM, et al. Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. Pediatr Infect Dis J. 2010 Mar;29(3):205–208.
   PubMed Web of Science ®Google Scholar
• Chen SY, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection. 2014 Apr;42(2):325–334.
   PubMed Web of Science ®Google Scholar
• Kawai K, Hawkins CA, Hertzmark E, et al. Impact of antiretroviral therapy on the risk of herpes zoster among human immunodeficiency virus-infected individuals in Tanzania. Am J Trop Med Hyg. 2018 Feb;98(2):396–401.
   PubMed Web of Science ®Google Scholar
• Yun H, Yang S, Chen L, et al. Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination. Arthritis Rheumatol. 2016 Sep;68(9):2328–2337.
   PubMed Web of Science ®Google Scholar
• Hansson E, Forbes HJ, Langan SM, et al. Herpes zoster risk after 21 specific cancers: population-based case-control study. Br J Cancer. 2017 Jun 6;116(12):1643–1651.
   PubMed Web of Science ®Google Scholar
• Habel LA, Ray GT, Silverberg MJ, et al. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):82–90.
   PubMed Web of Science ®Google Scholar
• Hata A, Kuniyoshi M, Ohkusa Y. Risk of herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection. 2011 Dec;39(6):537–544.
   PubMed Web of Science ®Google Scholar
• Khan N, Patel D, Trivedi C, et al. Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a nationwide cohort study. Clin Gastroenterol Hepatol. 2018 Dec;16(12):1919–1927.e3.
   PubMed Web of Science ®Google Scholar
• Lin HC, Chao YH, Wu KH, et al. Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study. Medicine (Baltimore). 2016 Jul;95(30):e4037.
   PubMed Web of Science ®Google Scholar
• Fernández-Ruiz M, Origüen J, Lora D, et al. Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study. Transpl Int. 2018 Feb;31(2):187–197.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Dahl RM, Dooling KL. Prevalence of Immunosuppression among US adults, 2013. JAMA. 2016 Dec 20;316(23):2547–2548.
   PubMed Web of Science ®Google Scholar
• Ward BW, Schiller JS. Prevalence of multiple chronic conditions among US adults: estimates from the national health interview survey, 2010. Prev Chronic Dis. 2013;10:120203.
   Web of Science ®Google Scholar
• Joesoef RM, Harpaz R, Leung J, et al. Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc. 2012 Oct;87(10):961–967.
   PubMed Web of Science ®Google Scholar
• Forbes HJ, Bhaskaran K, Thomas SL, et al. Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014 May 13;348:g2911.
   PubMed Web of Science ®Google Scholar
• Lai SW, Lin CL, Liao KF. Chronic pancreatitis correlates with increased risk of herpes zoster in a population-based retrospective cohort study. J Hepatobiliary Pancreat Sci. 2018 Sep;25(9):412–417.
   PubMed Web of Science ®Google Scholar
• Lai SW, Lin CH, Lin HF, et al. Herpes zoster correlates with increased risk of Parkinson’s disease in older people: A population-based cohort study in Taiwan. Medicine (Baltimore). 2017 Feb;96(7):e6075.
   PubMed Web of Science ®Google Scholar
• Yang YW, Chen YH, Lin HW. Risk of herpes zoster among patients with psychiatric diseases: a population-based study. J Eur Acad Dermatol Venereol. 2011 Apr;25(4):447–453.
   PubMed Web of Science ®Google Scholar
• Wu PH, Lin YT, Kuo CN, et al. No increased risk of herpes zoster found in cirrhotic patients: a nationwide population-based study in Taiwan. PLoS One. 2014 Apr 3;9(4):e93443.
   PubMed Web of Science ®Google Scholar
• Hsia SV, Chen LH, Tseng HF. Receipt of thyroid hormone deficiency treatment and risk of herpes zoster. Int J Infect Dis. 2017 Jun;59:90–95.
   PubMed Web of Science ®Google Scholar
• Norman J, Politz D. Shingles (varicella zoster) outbreaks in patients with hyperparathyroidism and their relationship to hypercalcemia. Clin Infect Dis. 2008 May 1;46(9):1452–1454.
   PubMed Web of Science ®Google Scholar
• Kim MC, Yun SC, Lee SO, et al. Statins increase the risk of herpes zoster: A propensity score-matched analysis. PLoS One. 2018 Jun 14;13(6):e0198263.
   PubMed Web of Science ®Google Scholar
• Lai SW, Lin CL. Patients with appendectomy are at increased risk of herpes zoster: real-world data in Taiwan. Intern Emerg Med. 2019;14(2):329–330.
   Web of Science ®Google Scholar
• Wu FJ, Kao LT, Sheu SY, et al. Increased risk of a herpes zoster attack in patients receiving androgen deprivation therapy for prostate cancer. Andrologia. 2018;e12863.
   Web of Science ®Google Scholar
• Chung WS, Lin HH, Cheng NC, et al. Risk of herpes zoster in patients with sleep disorders: a population-based cohort study. Medicine (Baltimore). 2016 Mar;95(11):e2195.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Hens N, Pebody R, et al. Cytomegalovirus seropositivity is associated with herpes zoster. Hum Vaccin Immunother. 2015;11(6):1394–1399.
   PubMed Web of Science ®Google Scholar
• Singh GK, Deora MS, Grewal R, et al. Is high altitude a risk factor in development of herpes zoster? High Alt Med Biol. 2018 Sep;19(3):244–248.
   PubMed Web of Science ®Google Scholar
• Termorshuizen F, Hogewoning AA, Bouwes, et al. Skin infections in renal transplant recipients and the relation with solar ultraviolet radiation. Clin Transplant. 2003 Dec;17(6):522–527.
   PubMed Web of Science ®Google Scholar
• Reyes DP, Brinley AA, Blue RS, et al. Clinical herpes zoster in antarctica as a model for spaceflight. Aerosp Med Hum Perform. 2017 Aug 1;88(8):784–788.
   PubMed Web of Science ®Google Scholar
• Chao CT, Lai CF, Huang JW. Risk factors for herpes zoster reactivation in maintenance hemodialysis patients. Eur J Intern Med. 2012 Dec;23(8):711–715.
   PubMed Web of Science ®Google Scholar
• Lai YC, Yew YW. Risk of herpes zoster and family history: A meta-analysis of case-control studies. Indian J Dermatol. 2016 Mar-Apr;61(2):157–162.
   PubMed Web of Science ®Google Scholar
• Suo L, Lu L, Li J, et al. A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China. BMC Infect Dis. 2017 May 9;17(1):334.
   PubMedGoogle Scholar
• Tseng HF, Chi M, Hung P, et al. Family history of zoster and risk of developing herpes zoster. Int J Infect Dis. 2018;66:99–106.
   PubMed Web of Science ®Google Scholar
• Marin M, Harpaz R, Zhang J, et al. Risk Factors for Herpes Zoster Among Adults. Open Forum Infect Dis. 2016 Jun 11;3(3):ofw119.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Shipley SJ, Dobson CB, et al. Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein Barr virus? Eur J Hum Genet. 2007 Jun;15(6):672–678. Epub 2007 Mar 14
   PubMed Web of Science ®Google Scholar
• Tian C, Hromatka BS, Kiefer AK, et al. Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun. 2017 Sep 19;8(1):599.
   PubMedGoogle Scholar
• Stanaway IB, Hall TO, Rosenthal EA, et al. The eMERGE genotype set of 83,717 subjects imputed to ~40 million variants genome wide and association with the herpes zoster medical record phenotype. Genet Epidemiol. 2019 Feb;43(1):63–81.
   PubMed Web of Science ®Google Scholar
• Crosslin DR, Carrell DS, Burt A, et al. Genetic variation in the HLA region is associated with susceptibility to herpes zoster. Genes Immun. 2015;16:1–7.
   PubMed Web of Science ®Google Scholar
• Thomas SL, Wheeler JG, Hall AJ. Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ. 2004;328(7437):439.
   PubMedGoogle Scholar
• Zhang JX, Joesoef RM, Bialek S, et al. Association of physical trauma with risk of herpes zoster among medicare beneficiaries in the United States. J Infect Dis. 2013;207(6):1007–1011.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Wollan PC, Kurland MJ, et al. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011 Feb;86(2):88–93.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Miyagawa F, Okazaki A, et al.; Shozu Herpes Zoster Study Group. Clinical and immunologic features of recurrent herpes zoster (HZ). J Am Acad Dermatol. 2016 Nov;75(5):950–956.e1.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Toyama N, Daikoku T, et al. Dermatologist society. Herpes Zoster and recurrent herpes zoster. Open Forum Infect Dis. 2017 Jan 28;4(1):ofx007.
   PubMed Web of Science ®Google Scholar
• Weinberg A, Zhang JH, Oxman MN, et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis. 2009 Oct 1;200(7):1068–1077.
   PubMed Web of Science ®Google Scholar
• Warren-Gash C, Forbes H, Maple P, et al. Viral load and antibody boosting following herpes zoster diagnosis. J Clin Virol. 2018;103:12–15.
   PubMed Web of Science ®Google Scholar
• Levin MJ. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. J Clin Virol. 2014 Dec;61(4):487–495.
   PubMed Web of Science ®Google Scholar
• Wilson A, Sharp M, Koropchak CM, et al. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis. 1992;165:119–126.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Lönnqvist B, Gahrton G, et al. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis. 1986 May;153(5):840–847.
   PubMed Web of Science ®Google Scholar
• Weigle KA, Grose C. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation. J Infect Dis. 1984 May;149(5):741–749.
   PubMed Web of Science ®Google Scholar
• Arvin AM, Koropchak CM, Wittek AE. Immunological evidence of reinfection with varicella-zoster virus. J Infect Dis. 1983;148:200–205.
   PubMed Web of Science ®Google Scholar
• Terada K, Kawano S, Yoshihiro K, et al. Proliferative response to varicella-zoster virus is inverse related to development of high levels of varicella-zoster virus specific IgG antibodies. Scand J Infect Dis. 1993;25(6):775–778.
   PubMed Web of Science ®Google Scholar
• Terada K, Niizuma T, Yagi Y, et al. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination. J Med Virol. 2000 Sep;62(1):46–51.
   PubMed Web of Science ®Google Scholar
• Vossen MT, Gent MR, Weel JF, et al. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus. J Infect Dis. 2004;190:72–82.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Smits E, Hens N, et al. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents. Viral Immunol. 2011 Apr;24(2):151–157.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Smits E, Heynderickx S, et al. Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians. Clin Vaccine Immunol. 2014 Mar;21(3):417–426.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Van Den Bergh J, Meysman P, et al. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Sci Rep. 2017 Apr 24;7(1):1077.
   PubMed Web of Science ®Google Scholar
• Elias G, Souquette A, Heynderickx S, et al. Altered CD4+ T-Cell immunity in nurses occupationally exposed to viral pathogens. Clin Exp Immunol. 2018;194(2):192–204.
   PubMed Web of Science ®Google Scholar
• Gilbert PB, Luedtke AR. Statistical learning methods to determine immune correlates of herpes zoster in vaccine efficacy trials. J Infect Dis. 2018 Sep 22;218(suppl_2):S99–S101.
   PubMedGoogle Scholar
• Toyama N, Shiraki K, Society of the Miyazaki Prefecture Dermatologists. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol. 2009 Dec; 81(12):2053–2058.
   PubMed Web of Science ®Google Scholar
• Chan DYW, Edmunds WJ, Chan HL, et al. The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014. Epidemiol Infect. 2018 Apr;146(6):723–734.
   PubMed Web of Science ®Google Scholar
• Wu PY, Wu HD, Chou TC, et al. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PLoS One. 2013;8(10):e77709.
   PubMed Web of Science ®Google Scholar
• Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008 Mar 25;5(3):e74.
   PubMed Web of Science ®Google Scholar
• Grossmann I, Varnum ME. Social structure, infectious diseases, disasters, secularism, and cultural change in America. Psychol Sci. 2015;26:311–324.
   PubMed Web of Science ®Google Scholar
• Marziano V, Poletti P, Guzzetta G, et al. The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study. Proc Biol Sci. 2015;282:20142509.
   PubMed Web of Science ®Google Scholar
• Horn J, Damm O, Greiner W, et al. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC Med. 2018 Jan 9;16(1):3.
   PubMedGoogle Scholar
• Melegaro A, Marziano V, Del Fava E, et al. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study. BMC Med. 2018 Jul 17;16(1):117.
   PubMedGoogle Scholar
• Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002;360:678–682.
   PubMed Web of Science ®Google Scholar
• Terada K, Hiraga Y, Kawano S, et al. Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster. Kansen Zasshi. 1995;69:908–912.
   PubMedGoogle Scholar
• Salleras M, Domínguez A, Soldevila N, et al. Contacts with children and young people and adult risk of suffering herpes zoster. Vaccine. 2011;29(44):7602–7605.
   PubMed Web of Science ®Google Scholar
• Solomon BA, Kaporis AG, Glass AT, et al. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). J Am Acad Dermatol. 1998;38:763–765.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R, Molinari NA, et al. Herpes zoster incidence among insured persons in the United States, 1993–2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011 Feb 1;52(3):332–340.
   PubMed Web of Science ®Google Scholar
• Donahue JG, Kieke BA, Gargiullo PM, et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Am J Public Health. 2010 Jun;100(6):1116–1122.
   PubMed Web of Science ®Google Scholar
• Lasserre A, Blaizeau F, Gorwood P, et al. Herpes zoster: family history and psychological stress-case-control study. J Clin Virol. 2012 Oct;55(2):153–157.
   PubMed Web of Science ®Google Scholar
• Gaillat J, Gajdos V, Launay O, et al. Does monastic life predispose to the risk of Saint Anthony’s fire (herpes zoster)? Clin Infect Dis. 2011 Sep;53(5):405–410.
   PubMed Web of Science ®Google Scholar
• Wu CY, Hu HY, Huang N, et al. Do the health-care workers gain protection against herpes zoster infection? A 6-year population-based study in Taiwan. J Dermatol. 2010 May;37(5):463–470.
   PubMed Web of Science ®Google Scholar
• Chaves SS, Santibanez TA, Gargiullo P, et al. Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S. 433021. 2007 Mar-Apr;122(2):155–159.
   Google Scholar
• Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61(5):310–316.
   PubMed Web of Science ®Google Scholar
• Jumaan AO, Yu O, Jackson LA, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J Infect Dis. 2005;191(12):2002–2007.
   PubMed Web of Science ®Google Scholar
• Hales CM, Harpaz R, Joesoef MR, et al. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159(11):739–745.
   PubMed Web of Science ®Google Scholar
• Hales CM Trends in herpes zoster incidence from 1940 to 2008 using a cross-sectional survey. Thesis, Georgia State University, 2015. Available at: http://scholarworks.gsu.edu/math_theses/149/. Last accessed on 2019 Jan 19.
   Google Scholar
• Caputo M, Horn J, Karch A, et al. Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort. BMC Infect Dis. 2019 Jan 30;19(1):99.
   PubMedGoogle Scholar
• Law BJ, Chateau D, Walld R, et al. Temporal trends in the annual population-based incidence of herpes zoster by age and gender: manitoba, 1979–1998. Can J Infect Dis Med Microbiol. 2004;15:357–358.
   Google Scholar
• Park SY, Kim JY, Kim CD, et al. A clinical study on herpes zoster during the last 10-yr-period (1994–2003). Korean J Dermatol. 2004;42:1531–1535.
   Google Scholar
• Smetana J, Salavec M, Bostiková V, et al. Herpes zoster in the Czech Republic – epidemiology and clinical manifestations. Epidemiol Mikrobiol Imunol. 2010;59(3):138–146.
   PubMed Web of Science ®Google Scholar
• Tanuseputro P, Zagorski B, Chan KJ, et al. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011 Nov 3;29(47):8580–8584.
   PubMed Web of Science ®Google Scholar
• Araújo LQ, Macintyre CR, Vujacich C. Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America. Herpes. 2007 Sep;14(Suppl 2):40–44.
   PubMedGoogle Scholar
• Harpaz R, Leung JW. The Epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis. 2019;69(2):341–344.
   Web of Science ®Google Scholar
• Dooling K, Zhang J, Guo A, et al. Incidence of herpes zoster in the pre- and post-vaccine era: do trends differ between blacks and whites? Open Forum Infect Dis. 2018 Nov;5((Suppl 1)): S751. 2018 Nov 26.
   Google Scholar
• Baxter R. Impact of vaccination on the epidemiology of varicella. Transl Pediatr. 2015;4(1):63–64.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC) AdultVaxView (2008 through 2014 Adult Vaccination Coverage Trend Report). [ cited 2019 Jul 26]. Available from: http://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/data-reports/general-population/Last
   Google Scholar
• Rimland D, Moanna A. Increasing incidence of herpes zoster among Veterans. Clin Infect Dis. 2010 Apr 1;50(7):1000–1005.
   PubMed Web of Science ®Google Scholar
• Moanna A, Rai R, Rimland D. Temporal trends of incidence of herpes zoster among veterans: a national . Anal Open Forum Infect Dis. 2016 December 1;3(suppl_1):628.
   Google Scholar
• Kelly HA, Grant KA, Gidding H, et al. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012. Euro Surveill. 2014 Oct 16;19(41):pii: 20926.
   Google Scholar
• Friesen KJ, Chateau D, Falk J, et al. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis. 2017 Jan 13;17(1):69.
   PubMed Web of Science ®Google Scholar
• Hilderman T, Katz A, Derksen S, et al. Manitoba immunization study. Winnipeg: Manitoba Centre for Health Policy; 2011 on 2019 Jan. 19. http://mchpappserv.cpe.umanitoba.ca/reference/MB_Immunization_Report_WEB.pdf
   Google Scholar
• Martel L Recent changes in demographic trends in Canada. Articles and reports: 75-006-X201500114240. X. [cited 2019 Jul 26]. Available from: https://www150.statcan.gc.ca/n1/pub/75-006-x/2015001/article/14240-eng.htm
   Google Scholar
• Morino S, Tanaka-Taya K, Satoh H, et al. Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000–2017. Vaccine. 2018 Sep 25;36(40):5977–5982.
   PubMed Web of Science ®Google Scholar
• Toyama N, Shiraki K,, . Universal varicella vaccination reduced the incidence of herpes zoster in vaccine recipients 1 to 4 years of age. J Dermatol Sci. 2018 Dec;92(3): 284–286
   PubMed Web of Science ®Google Scholar
• Toyama N, Shiraki K, Miyazaki Dermatologist Society. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect. J Dermatol Sci. 2018 Oct; 92(1):89–96.
   PubMed Web of Science ®Google Scholar
• Civen R, Marin M, Zhang J, et al. Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, antelope valley, CA, 2000 to 2010. Pediatr Infect Dis J. 2016 Oct;35(10):1132–1136.
   PubMed Web of Science ®Google Scholar
• Pham MA, Bednarczyk RA, Becker ER, et al. Trends in U.S. Community hospitalizations due to herpes zoster: 2001–2015. Vaccine. 2019;37(6):882–888.
   Web of Science ®Google Scholar
• Wormsbecker AE, Wang J, Rosella LC, et al. Twenty years of medically-attended pediatric varicella and herpes zoster in Ontario, Canada: A population-based study. PLoS One. 2015 Jul 15;10(7):e0129483. eCollection 2015. (see erratum).
   PubMed Web of Science ®Google Scholar
• Zoch-Lesniak B, Tolksdorf K, Siedler A. Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005–2016. Hum Vaccin Immunother. 2018 Jul 3;14(7):1807–1814.
   PubMed Web of Science ®Google Scholar
• Carryn S, Van Den Steen P, Oostvogels L, et al. No serologic evidence in adults 50 years and older that routine pediatric varicella vaccination programs influence their degree of exposure to varicella. Abstract ESP17-1162, 35TH Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), 2017 May 23–27, Madrid, Spain. [ cited on 2019 Jul 26]. Available from: http://espid2017.kenes.com/documents/espid17%20abstracts.docx.
   Google Scholar